BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34296805)

  • 1. CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma.
    Berico P; Cigrang M; Davidson G; Braun C; Sandoz J; Legras S; Vokshi BH; Slovic N; Peyresaubes F; Gene Robles CM; Egly JM; Compe E; Davidson I; Coin F
    EMBO Rep; 2021 Sep; 22(9):e51683. PubMed ID: 34296805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.
    Eliades P; Abraham BJ; Ji Z; Miller DM; Christensen CL; Kwiatkowski N; Kumar R; Njauw CN; Taylor M; Miao B; Zhang T; Wong KK; Gray NS; Young RA; Tsao H
    J Invest Dermatol; 2018 Jul; 138(7):1582-1590. PubMed ID: 29408204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repair.
    Seoane M; Buhs S; Iglesias P; Strauss J; Puller AC; Müller J; Gerull H; Feldhaus S; Alawi M; Brandner JM; Eggert D; Du J; Thomale J; Wild PJ; Zimmermann M; Sternsdorf T; Schumacher U; Nollau P; Fisher DE; Horstmann MA
    Oncogene; 2019 May; 38(19):3616-3635. PubMed ID: 30651597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
    Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.
    Grabacka M; Placha W; Urbanska K; Laidler P; Płonka PM; Reiss K
    Pigment Cell Melanoma Res; 2008 Jun; 21(3):388-96. PubMed ID: 18444964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.
    Vlčková K; Vachtenheim J; Réda J; Horák P; Ondrušová L
    J Cell Mol Med; 2018 Apr; 22(4):2240-2251. PubMed ID: 29369499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.
    Falletta P; Sanchez-Del-Campo L; Chauhan J; Effern M; Kenyon A; Kershaw CJ; Siddaway R; Lisle R; Freter R; Daniels MJ; Lu X; Tüting T; Middleton M; Buffa FM; Willis AE; Pavitt G; Ronai ZA; Sauka-Spengler T; Hölzel M; Goding CR
    Genes Dev; 2017 Jan; 31(1):18-33. PubMed ID: 28096186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
    Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
    PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells.
    Sestáková B; Ondrusová L; Vachtenheim J
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):238-51. PubMed ID: 20067556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions.
    Durand S; Tang Y; Pommier RM; Benboubker V; Grimont M; Boivin F; Barbollat-Boutrand L; Cumunel E; Dupeuble F; Eberhardt A; Plaschka M; Dalle S; Caramel J
    Oncogene; 2024 May; 43(20):1489-1505. PubMed ID: 38519642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
    Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
    Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MITF in melanoma: mechanisms behind its expression and activity.
    Hartman ML; Czyz M
    Cell Mol Life Sci; 2015 Apr; 72(7):1249-60. PubMed ID: 25433395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFATc2 is an intrinsic regulator of melanoma dedifferentiation.
    Perotti V; Baldassari P; Molla A; Vegetti C; Bersani I; Maurichi A; Santinami M; Anichini A; Mortarini R
    Oncogene; 2016 Jun; 35(22):2862-72. PubMed ID: 26387540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.
    Wellbrock C; Rana S; Paterson H; Pickersgill H; Brummelkamp T; Marais R
    PLoS One; 2008 Jul; 3(7):e2734. PubMed ID: 18628967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling axis.
    Shabna A; Antony J; Vijayakurup V; Saikia M; Liju VB; Retnakumari AP; Amrutha NA; Alex VV; Swetha M; Aiswarya SU; Jannet S; Unni US; Sundaram S; Sherin DR; Anto NP; Bava SV; Chittalakkottu S; Ran S; Anto RJ
    Cell Mol Life Sci; 2022 Aug; 79(9):478. PubMed ID: 35948813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.
    Fernández-Barral A; Orgaz JL; Baquero P; Ali Z; Moreno A; Tiana M; Gómez V; Riveiro-Falkenbach E; Cañadas C; Zazo S; Bertolotto C; Davidson I; Rodríguez-Peralto JL; Palmero I; Rojo F; Jensen LD; del Peso L; Jiménez B
    Neoplasia; 2014 Jun; 16(6):529-42. PubMed ID: 25030625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of MITF transcriptional activity independent of targeting p300/CBP coactivators.
    Vachtenheim J; Sestáková B; Tuhácková Z
    Pigment Cell Res; 2007 Feb; 20(1):41-51. PubMed ID: 17250547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BPTF transduces MITF-driven prosurvival signals in melanoma cells.
    Dar AA; Majid S; Bezrookove V; Phan B; Ursu S; Nosrati M; De Semir D; Sagebiel RW; Miller JR; Debs R; Cleaver JE; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6254-8. PubMed ID: 27185926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment.
    Riesenberg S; Groetchen A; Siddaway R; Bald T; Reinhardt J; Smorra D; Kohlmeyer J; Renn M; Phung B; Aymans P; Schmidt T; Hornung V; Davidson I; Goding CR; Jönsson G; Landsberg J; Tüting T; Hölzel M
    Nat Commun; 2015 Nov; 6():8755. PubMed ID: 26530832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.
    Lu S; Slominski A; Yang SE; Sheehan C; Ross J; Carlson JA
    J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):26-40. PubMed ID: 20482673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.